Skip to content

Perrigo Company PRGO Infant Formula — Total depreciation

Other segment segments

Self Care
$13.6M
Specialty Care
$3.2M

Similar metrics at other companies

Flex Ltd. logo
FLEXIntegrated Technology Solutions — Total depreciation expense
$40.5M-10.0%
Abbott logo
ABTNutritional Products — Depreciation
$50M+19.0%
Keysight Technologies logo
KEYSSegment Total — Depreciation
$32.75M+4.0%
Adient logo
ADNTDepreciation expense
-$68M-1.5%
Healthcare Services Group logo
HCSGDietary — Depreciation and amortization expense
$775K+6.9%
Teradata logo
TDCProduct Sales — Depreciation expense
$20M+25.0%

Other financials

Income statement

See full
Revenue$969.2M-7.2%
Gross profit$325.5M-17.0%
Operating income-$372.3M-894%
Net income-$398.6M-6,128%
EPS (diluted)-$2.87-5,640%

Balance sheet

See full
Cash & equivalents$357.2M-12.9%
Total debt$3.8B-0.6%
Total equity$2.5B-42.7%
Total assets$8.0B-18.2%

Cash flow

See full
Operating cash flow-$113.6M-76.1%
CapEx$13.8M-45.9%
Free cash flow-$127.4M-41.6%

Valuation

See full
Market cap$1.35B-62.9%
Enterprise value$4.82B-32.0%
P/S0.3×-0.5×

Profitability

See full
Gross margin34.2%-2.2pp
Operating margin-36.9%-41.8pp
Net margin-43.5%-48.6pp
FCF margin4.2%-2.0pp

Returns & leverage

See full
Return on equity-53%-57.7pp
Debt / equity1.5×+0.6×
Current ratio2.7×+0.4×

Where this comes from

Reported directly by Perrigo Company in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Perrigo Company’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perrigo Company's infant formula — total depreciation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perrigo Company's infant formula — total depreciation?
Perrigo Company (PRGO) reported infant formula — total depreciation of $7.7M in Q1 2026.
What does infant formula — total depreciation mean?
This represents the systematic allocation of the cost of tangible assets, such as manufacturing equipment and facilities, used in the infant formula segment over their useful lives. It is a non-cash expense that reflects the ongoing capital intensity of the production process. Tracking this helps investors understand the segment's reinvestment requirements and asset aging.